BAG3P215L/KO Mice as a Model of BAG3P209L Myofibrillar Myopathy

Rebecca Robertson, Talita C. Conte, Marie Josée Dicaire, Vladimir V. Rymar, Abbas F. Sadikot, Robert J. Bryson-Richardson, Josée N. Lavoie, Erin O'Ferrall, Jason C. Young, Bernard Brais

Research output: Contribution to journalArticleResearchpeer-review

Abstract

BCL-2–associated athanogene 3 (BAG3) is a co-chaperone to heat shock proteins important in degrading misfolded proteins through chaperone-assisted selective autophagy. The recurrent dominant BAG3-P209L mutation results in a severe childhood-onset myofibrillar myopathy (MFM) associated with progressive muscle weakness, cardiomyopathy, and respiratory failure. Because a homozygous knock-in (KI) strain for the mP215L mutation homologous to the human P209L mutation did not have a gross phenotype, compound heterozygote knockout (KO) and KI mP215L mice were generated to establish whether further reduction in BAG3 expression would lead to a phenotype. The KI/KO mice have a significant decrease in voluntary movement compared with wild-type and KI/KI mice in the open field starting at 7 months. The KI/KI and KI/KO mice both have significantly smaller muscle fiber cross-sectional area. However, only the KI/KO mice have clear skeletal muscle histologic changes in MFM. As in patient muscle, there are increased levels of BAG3-interacting proteins, such as p62, heat shock protein B8, and αB-crystallin. The KI/KO mP215L strain is the first murine model of BAG3 myopathy that resembles the human skeletal muscle pathologic features. The results support the hypothesis that the pathologic development of MFM requires a significant decrease in BAG3 protein level and not only a gain of function caused by the dominant missense mutation.

Original languageEnglish
Pages (from-to)554-562
Number of pages9
JournalAmerican Journal of Pathology
Volume190
Issue number3
DOIs
Publication statusPublished - Mar 2020

Cite this